Patients, Patents, and Pharmaceutical Industry MCQs

Patients, Patents, and Pharmaceutical Industry MCQs

Answer these 30+ Patients, Patents, and Pharmaceutical Industry MCQs and assess your grip on the subject of Patients, Patents, and Pharmaceutical Industry.
Scroll below and get started!

1: _______is a Protection of any new, original, and ornamental design for an article of manufacture?

A.   Tippee

B.   Temporary insider

C.   Design patent

D.   Intellectual property

2: An attempt to “refresh” a patented product by making a modification to the drug’s delivery mechanism, its dosage, or other characteristics is known as ?

A.   Temporary insider

B.   Design patent

C.   Intellectual property

D.   Evergreening

3: _________ any intangible objects or assets (such as software programs, music, or books)?

A.   Intellectual property

B.   Trademark

C.   Intellectual work

D.   Composition

A.   Patent

B.   Patent cliff

C.   Process patent

D.   Product patent

5: The ______ expiration of patents on well-known blockbuster drugs?

A.   Patent

B.   Patent cliff

C.   Process patent

D.   Product patent

6: Protection of a means of doing something is known as?

A.   Patent

B.   Patent cliff

C.   Process patent

D.   Product patent

7: Protection of inventions or functional devices such as machines,__________, or “compositions of matter”

A.   Articles of manufacture

B.   Manufactured items

C.   Manufactured products

D.   Manufactured material

8: ________(it is difficult or even impossible to exclude or “fence out” people)?

A.   Nonexclusive

B.   Universal

C.   Nonspecific

D.   Comprehensive

9: Protection of any new, useful, and nonobvious process, machine, or article of manufacture is known as ?

A.   Utility patent

B.   Patent cliff

C.   Process patent

D.   Product patent

10: Vertically integrated is the structure of a company that performs all value chain activities in house, from research and development to manufacturing and marketing?

A.   True

B.   False

11: Which kind of property consists of intangible assets and objects?

A.   Intellectual

B.   Physical

C.   Utility

D.   Private

12: Public goods are _____ objects.

A.   Individual

B.   Intangible

C.   Protected

D.   Consumer

A.   Secure

B.   Intellectual

C.   Investment

D.   Utility

A.   Both are concept goods.

B.   Both are private goods.

C.   Both are public goods.

D.   Both are design goods.

15: What type of intellectual property would an author need to legally protect their book?

A.   Invention

B.   Patent

C.   Trademark

D.   Copyright

16: For an original idea to be eligible for ______, it must be expressed in some tangible medium.

A.   Patent

B.   Trademark

C.   Copyright

D.   Invention

A.   Asset

B.   Expression

C.   Patent

D.   Product

18: What did the judge mean when he remarked “a patent is not a hunting license,” as he refused a patent?

A.   Patents are for hunting for a cure.

B.   Patents should be possible in a competitive market.

C.   Patents are for testing with or without useful results.

D.   Patents that have no useful results are not acceptable.

19: What are the three forms of patents?

A.   Design, utility, and plant

B.   Process, product, and plant

C.   Public, utility, and process

D.   Design, process, and product

20: What are the requirements for a patent to be granted?

A.   Research, consistencies, and profits

B.   Design, exclusiveness, and research

C.   Utility, new, and nonobvious

D.   Profits, relevance, and design

A.   Plant

B.   Process

C.   Design

D.   Utility

22: A machine is an example of a ______.

A.   Product patent

B.   Process patent

C.   Trademark

D.   Copyright

23: No matter what form of patent, the law requires ______ years before any other company may reproduce that patent.

A.   22

B.   23

C.   21

D.   20

24: The pharmaceutical industry depends more heavily on patents to protect its ______ and thereby ensure a return on its investment.

A.   Profit

B.   Innovations

C.   Public

D.   Marketing

25: This term refers to major pharmaceutical companies dominating the sale and distribution of prescriptions.

A.   Benkler

B.   Cipla

C.   Big Pharma

D.   Shkreli

26: What type of patent protects any new, useful, and nonobvious process, machine, or article of manufacture?

A.   Design

B.   Process

C.   Product

D.   Utility

27: Which act did Congress pass that is dedicated to food safety and prohibits misbranding of drugs?

A.   Wiley Act

B.   Federal Food Drug and Cosmetic Act

C.   Import Drug Act

D.   Orphan Drug Act

28: How did the Federal Food, Drug, and Cosmetic Act change drug manufacturing?

A.   By requiring labeling requirements and warnings

B.   By requiring drugs to be more affordable for patients

C.   By requiring the rapid production of the drug

D.   By requiring a delay in drug availability

29: What does “patent cliff” mean to pharmaceutical industries?

A.   The drug will no longer be effective.

B.   Their product is no longer protected from competition.

C.   The company will lose its trademark.

D.   Their product is no longer available.

30: For a patented drug to be eligible for a new patent, the pharmaceutical company has to ______.

A.   Decide if only blockbuster drugs are eligible

B.   Be owned by the same developer

C.   Modify the drug’s delivery mechanism

D.   Be sure the product is outdated

31: What did Pfizer do when they heard doctors were less likely to prescribe new drugs if the cost was over $10,000?

A.   Kept the price the same, knowing the drug was needed

B.   Lowered the price of their drug to $9850 for profit

C.   Lowered their price to $9,999 to keep up with the competitors

D.   Made their product no longer available

32: What is Valeant's defense on the cost of drugs?

A.   Focus should be placed on lowering drug costs rather than emphasizing shareholders’ wealth.

B.   Parties should agree to lower drug costs and make it easier for generic manufacturers to gain access to drug formulations.

C.   Drugs should be donated to the consumers to keep the profit away from generic manufacturers.

D.   It is appropriate to maintain high drug prices for maximum profits and to make it more difficult for generic manufacturers to gain access to drug formulations.

33: The ______ of natural DNA does not alter its inherent characteristics; isolated DNA remains a product of nature.

A.   Composition

B.   Purification

C.   Stabilization

D.   Conclusion

34: Why is cDNA patentable and DNA is not?

A.   CDNA contains fewer genes.

B.   CDNA is a product of nature.

C.   CDNA is not a product of nature.

D.   CDNA has no genes.

35: How did the Orphan Act encourage the pharmaceutical industry to invest in treatments for rare diseases?

A.   By proving patent right for 40 years

B.   By providing low-interest loans

C.   By privately funding the company

D.   By providing federal funding of grants

36: Privacy is one way of protecting ourselves from physical, emotional, and economic harm. What level of security is this?

A.   Business

B.   Personal

C.   Group

D.   National

37: The acronym sludge helps identify the effects of ________ drugs on the autonomic nervous system.

A.   Sympathomimetic

B.   Sympatholytic

C.   Parasympathomimetic

D.   Parasympatholytic